Borer Denton & Associates’s Eli Lilly LLY Stock Holding History

Borer Denton & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.44M	Hold	2,652	–	–	0.87%	28
2025 Q4	$2.85M	Hold	2,652	–	–	0.96%	27
2025 Q3	$2.02M	Sell	2,652 -6	-0.2%	-$4.46K	0.67%	31
2025 Q2	$2.07M	Hold	2,658	–	–	0.72%	31
2025 Q1	$2.19M	Buy	2,658 +183	+7%	+$152K	0.78%	31
2024 Q4	$1.91M	Hold	2,475	–	–	0.66%	31
2024 Q3	$2.19M	Hold	2,475	–	–	0.75%	30
2024 Q2	$2.24M	Hold	2,475	–	–	0.81%	29
2024 Q1	$1.93M	Hold	2,475	–	–	0.68%	32
2023 Q4	$1.44M	Hold	2,475	–	–	0.55%	33
2023 Q3	$1.33M	Hold	2,475	–	–	0.55%	33
2023 Q2	$1.16M	Hold	2,475	–	–	0.46%	35
2023 Q1	$850K	Buy	2,475 +110	+5%	+$37.1K	0.35%	38
2022 Q4	$865K	Buy	2,365 +800	+51%	+$284K	0.38%	37
2022 Q3	$506K	Sell	1,565 -172	-10%	-$54.5K	0.25%	43
2022 Q2	$563K	Hold	1,737	–	–	0.27%	42
2022 Q1	$497K	Buy	+1,737	New	+$447K	0.21%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Borer Denton & Associates's LLY Position: Q1 2026 in Review

Borer Denton & Associates held its Eli Lilly (LLY) position steady in Q1 2026 at 2,652 shares worth $2.44M. The position accounts for 0.87% of the portfolio, ranked #28.

Borer Denton & Associates first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.85M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Borer Denton & Associates held 2,652 shares of Eli Lilly worth $2.44M as of Q1 2026.
Borer Denton & Associates left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.87% of Borer Denton & Associates's portfolio in Q1 2026, its #28 holding.
Borer Denton & Associates first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
Borer Denton & Associates's Eli Lilly position peaked at $2.85M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Borer Denton & Associates's 13F filing for Q1 2026, filed 12 May 2026.